Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
US Allows Increased Production Of Takeda’s ADHD Drug to Address Shortage
(Reuters) – The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% to address the medicine’s ongoing shortage in the United States. The raised production limit…
English